Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong · Delayed Price · Currency is HKD 4.100
+0.215 (5.53%)
Oct 21, 2026, 2:45 PM HKT
Lepu Biopharma Market Cap
Lepu Biopharma has a market cap or net worth of 7.4 billion as of October 20, 2026. It is the 10,634th most valuable company in the world and the 522nd biggest in Hong Kong. Its market cap has decreased by 37.50% in one year.
Market Cap
7.40B
Enterprise Value
7.82B
Revenue
1.14B
Global Rank
Country Rank
#522 Hong Kong
PE Ratio
24.55
ChartMarket Cap Chart
Since February 23, 2022, Lepu Biopharma's market cap has decreased from 11.84B to 7.40B, a decrease of -37.53%. That is a compound annual growth rate of -9.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 7.40B | -17.51% |
| Dec 31, 2025 | 8.97B | 100.10% |
| Dec 31, 2024 | 4.48B | -35.85% |
| Dec 29, 2023 | 6.99B | -42.72% |
| Dec 30, 2022 | 12.20B | 3.00% |
| Feb 23, 2022 | 11.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Suzhou Ribo Life Science | 8.91B |
| HBM Holdings | 8.64B |
| Nanjing Leads Biolabs | 8.38B |
| CStone Pharmaceuticals | 8.09B |
| Shanghai Haohai Biological Technology | 7.27B |
| Alphamab Oncology | 6.84B |
| CARsgen Therapeutics Holdings | 6.78B |
| Ascletis Pharma | 6.05B |